328 results
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
any grant of stock, stock options or other equity based awards (including any long-term management equity incentive 16
plans) and the payment … Group on a Consolidated basis, the sum of (a) the outstanding principal amount of all obligations, whether current or long-term, for borrowed money
8-K
EX-99.2
LFCR
Lifecore Biomedical Inc
1 Apr 24
Results of Operations and Financial Condition
8:07am
Large, growing addressable markets with attractive underlying tailwinds supported by long-term customer relationships and low turnover 40+ years … levers to continue to drive long-term growth, including continued expansion and commercialization of development pipeline
5 74% 26% HA Raw Material
8-K
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
performance and the leadership of WSS, which has approximately 450 employees. He led initiatives to develop and implement long-term strategic and annual
8-K
EX-10.2
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
, Inc. Equity Inducement Plan (the “Plan”) will be effective on the Effective Date.
1.2 The purpose of the Plan is to promote the long-term success … that the Participant is classified as disabled under a long-term disability policy of the Company or, if no such policy applies, the Participant is unable
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
commercial experience and long-term relationships in the CDMO business to build upon the great work of Lifecore’s team,” stated Nelson Obus, Director
8-K
EX-10.3
avn4ivv
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-99.1
41ooxxrr24be59b
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-99.1
bypw9j0mvf eq40oqklp
31 Aug 23
Results of Operations and Financial Condition
7:39am
8-K
EX-99.1
dxuq50a2o8e6y5
1 Jun 23
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
7:29am
8-K
EX-10.3
glcp9l461
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.5
57pnjj
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-99.1
bfrod0xefmyaq7ldvu
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
vyjze7 jb
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-99.1
tque23xn
6 Apr 23
Regulation FD Disclosure
4:10pm